This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Despite increased public attention on the epidemic of prescription medication abuse, about three in five Americans tested misused their prescription...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Sukumar Nagendran, M.D., has...
A new test based on gene sequencing may be used to assess a patient's suitability for treatment with CCR5 antagonists, a class of HIV antiretroviral...
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability...
On World Kidney Day, Quest Diagnostics, the world's leading provider of diagnostic information services, today announced its support of the updated...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that Robert A. Hagemann, Senior Vice...
Job candidates subject to pre-employment drug screening tested positive for illicit drugs at a greater rate in the first six months of 2012 than in...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is presenting its award-winning healthcare information...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that that it has been recognized in...